For in vitro diagnostic use. Others Elecsys HCG plus beta IVD Elecsys® HCG+β CPS_000481 03271749160 HCG+beta Elecsys cobas e 100 V2 Elecsys HCG+beta 04015630939022 Reagents, kits 100 tests cobas e 411/601/602 true 07251025214 HCG+beta Elecsys E2G 300 Elecsys HCG+beta 07613336193822 Reagents, kits 300 tests cobas e 402/801 true 09744428190 HCG+beta Elecsys E2G 100 V1 Elecsys HCG+ß 07613336217535 Reagents, kits 100 tests cobas e 402/801 true 07251025190 HCG+beta Elecsys E2G 300 Elecsys HCG+beta 04015630939732 Reagents, kits 300 tests cobas e 402/801 true 03271749190 HCG+beta Elecsys cobas e 100 V2 Elecsys HCG+beta 04015630919413 Reagents, kits 100 tests cobas e 411/601/602 true 03271749501 Elecsys HCG + β en 19 FF000000067E100E FF0000000034D20E 03271749160 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of the sum of human chorionic gonadotropin (hCG) plus the hCG β‑subunit in human serum and plasma.This assay is intended for the early detection of pregnancy.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07251025500 Elecsys HCG+β en 8 FF000000063A750E FF000000063A750E 07251025190 07251025214 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of the sum of human chorionic gonadotropin (hCG) plus the hCG β‑subunit in human serum and plasma.This assay is intended for use as an aid in:Early detection and monitoring of pregnancy. The test is also intended for the use as one component in combination with other parameters to evaluate the risk of trisomy 21 (Down syndrome). Further testing is required for diagnosis of chromosomal aberrations.Oncology, to serve the management of patients with trophoblastic diseases. This assay is useful in the detection and monitoring of hCG‑producing tumor cells of either ovarian, placental or testicular origin.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 09744428501 Elecsys HCG+β en 1 FF00000006CB9C0E FF00000006CB9C0E 09744428190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of the sum of human chorionic gonadotropin (hCG) plus the hCG β‑subunit in human serum and plasma.This assay is intended for the early detection of pregnancy.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07251025500 Elecsys HCG+β en 7 FF00000005D9FA0E FF000000044F160E 07251025190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of the sum of human chorionic gonadotropin (hCG) plus the hCG β‑subunit in human serum and plasma.This assay is intended for use as an aid in:Early detection and monitoring of pregnancy. The test is also intended for the use as one component in combination with other parameters to evaluate the risk of trisomy 21 (Down syndrome). Further testing is required for diagnosis of chromosomal aberrations.Oncology, to serve the management of patients with trophoblastic diseases. This assay is useful in the detection and monitoring of hCG‑producing tumor cells of either ovarian, placental or testicular origin.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07251025500 Elecsys HCG+β en 3 FF00000003FF340E FF00000001789B0E 07251025190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of the sum of human chorionic gonadotropin (hCG) plus the hCG β‑subunit in human serum and plasma.This assay is intended for use as an aid in:Early detection and monitoring of pregnancy. The test is also intended for the use as one component in combination with other parameters to evaluate the risk of trisomy 21 (Down syndrome). Further testing is required for diagnosis of chromosomal aberrations.Oncology, to serve the management of patients with trophoblastic diseases. This assay is useful in the detection and monitoring of hCG‑producing tumor cells of either ovarian, placental or testicular origin.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 801 immunoassay analyzer. en 07251025501 Elecsys HCG+β en 4 FF0000000649FE0E FF00000001C3760E 07251025190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of the sum of human chorionic gonadotropin (hCG) plus the hCG β‑subunit in human serum and plasma.This assay is intended for the early detection of pregnancy.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 03271749500 Elecsys HCG+β en 20 FF000000047C760E FF0000000017DF0E 03271749190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of the sum of human chorionic gonadotropin (hCG) plus the hCG β‑subunit in human serum and plasma.This assay is intended for use as an aid in:Early detection and monitoring of pregnancy. The test is also intended for the use as one component in combination with other parameters to evaluate the risk of trisomy 21 (Down syndrome). Further testing is required for diagnosis of chromosomal aberrations.Oncology, to serve the management of patients with trophoblastic diseases. This assay is useful in the detection and monitoring of hCG‑producing tumor cells of either ovarian, placental or testicular origin.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en